TROW
42
-5
NOC
32
-5
PEG
44
-2
EL
39
-6
JNPR
54
-4
MCHP
42
-7
PLD
48
-2
MU
35
-8
ALL
48
5
FMC
58
14
V
58
2
ISRG
70
-3
HRB
56
2
GRMN
71
22
XRX
24
-3
AKAM
56
-3
SHW
56
-2
APD
52
-2
XEL
48
-2
MSFT
54
-3
TROW
42
-5
NOC
32
-5
PEG
44
-2
EL
39
-6
JNPR
54
-4
MCHP
42
-7
PLD
48
-2
MU
35
-8
ALL
48
5
FMC
58
14
V
58
2
ISRG
70
-3
HRB
56
2
GRMN
71
22
XRX
24
-3
AKAM
56
-3
SHW
56
-2
APD
52
-2
XEL
48
-2
MSFT
54
-3
Financhill
Back

Cintas Vs. Kymera Therapeutics Industry Stock Comparison

Buy
52

CTAS
Cintas

Last Price:
205.75
Seasonality Move:
7.12%
Buy
62

KYMR
Kymera Therapeutics

Last Price:
46.17
Seasonality Move:
69.6%
Buy
52
Cintas (CTAS) is a Buy

Is Cintas a Buy, Sell or Hold?

  • The current Cintas [CTAS] share price is $207.90. The Score for CTAS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CTAS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CTAS Stock Price Chart

What is Cintas's stock price today?

  • The Cintas share price today is $207.90
    The current trend is moderately bearish and CTAS is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $47.65
    The current trend is moderately bearish and KYMR is experiencing slight selling pressure.

CTAS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.46 Buy
Relative Strength Index (14 RSI): 50.44 Buy
Chaikin Money Flow: -322331 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (205.07 - 210.93) Sell
Bollinger Bands (100): (181.02 - 206.1) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.6 Buy
Relative Strength Index (14 RSI): 52.44 Buy
Chaikin Money Flow: -88534 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.05 - 49.09) Buy
Bollinger Bands (100): (36.61 - 48.91) Buy

CTAS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 209.37 Sell
20-day SMA: 208.68 Sell
50-day SMA: 204.57 Buy
200-day SMA: 177.8 Buy
8-day EMA: 209.02 Sell
20-day EMA: 208.35 Sell
50-day EMA: 203.57 Buy
200-day EMA: 179.97 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.2 Sell
20-day SMA: 46.01 Buy
50-day SMA: 47.06 Buy
200-day SMA: 39.57 Buy
8-day EMA: 47.93 Sell
20-day EMA: 47.19 Buy
50-day EMA: 46.06 Buy
200-day EMA: 39.32 Buy

Cintas Earnings Growth & CTAS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and an increase next year of $0.50 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Cintas Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):